Inventor · disambiguated record
Thomas Müller
Also filed as: MUELLER THOMAS · MULLER THOMAS · MÜLLER THOMAS J J · Müller Thomas
22 granted patents·14 pending applications·115 citations·filing 1999–2024
94Inventor score
Top patents by PatentIndex Score
36 records- 0196US8106211B2Substituted enaminocarbonyl compoundsJESCHKE PETER·Filed 2007·Granted Jan 31, 2012·19 cites·12 claims
- 0295US8106212B2Substituted enaminocarbonyl compoundsJESCHKE PETER·Filed 2007·Granted Jan 31, 2012·15 cites·13 claims
- 0394US11130745B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2020·Granted Sep 28, 2021·4 cites·19 claims
- 0493US8404855B2Substituted enaminocarbonyl compoundsJESCHKE PETER·Filed 2011·Granted Mar 26, 2013·10 cites·6 claims
- 0591US8084452B2Substituted enaminocarbonyl compounds used as insecticidesJESCHKE PETER·Filed 2007·Granted Dec 27, 2011·21 cites·17 claims
- 0689US10815215B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2017·Granted Oct 27, 2020·5 cites·20 claims
- 0787US11713304B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2021·Granted Aug 1, 2023·1 cites·11 claims
- 0885US10435403B2Positive allosteric modulators of muscarinic M2 receptorBayer Pharma AG·Filed 2016·Granted Oct 8, 2019·7 cites·8 claims
- 0984US10414765B2Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of sameBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·4 cites·8 claims
- 1082US10759794B22-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disordersBayer Pharma AG·Filed 2016·Granted Sep 1, 2020·3 cites·31 claims
- 1178US12486248B22,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODHBAYER AG·Filed 2023·Granted Dec 2, 2025·0 cites·21 claims
- 1276US2025154175A1Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2024·Application pending·0 cites
- 1375US11098063B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2018·Granted Aug 24, 2021·1 cites·13 claims
- 1471US6794149B1GABA B receptorsBAYER AG·Filed 2000·Granted Sep 21, 2004·1 cites·1 claims
- 1567US12180227B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 1666US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1762US6723718B2Substituted α, β-anellated butyrolactonesBAYER AG·Filed 2002·Granted Apr 20, 2004·1 cites·11 claims
- 1861US6462074B1Substituted α, β-anellated butyrolactonesBAYER AG·Filed 1999·Granted Oct 8, 2002·17 cites·8 claims
- 1960US9174960B2Compounds useful against kinetoplastideae parasitesDAVIOUD-CHARVET ELISABETH·Filed 2010·Granted Nov 3, 2015·2 cites·10 claims
- 2060US2010173943A1Insecticidal compositions with improved actionBAYER CROPSCIENCE AG·Filed 2008·Application pending·0 cites
- 2159US2023065629A1Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2259US2022259228A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2021·Application pending·0 cites
- 2359US2005136511A1GABA B receptorsFiled 2004·Application pending·0 cites
- 2452US2023151442A1Rapid detection of viral infection using rt-pcrBAYER AG·Filed 2021·Application pending·0 cites
- 2551US11208400B2Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2017·Granted Dec 28, 2021·0 cites·17 claims
- 2651US2019367516A1Positive allosteric modulators of muscarinic m2 receptorBayer Pharma AG·Filed 2019·Application pending·0 cites
- 2750US2021024545A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2017·Application pending·0 cites
- 2844US2017037028A1Glucose transport inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2936US11208422B2Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitorsBayer Pharma AG·Filed 2018·Granted Dec 28, 2021·0 cites·19 claims
- 3036US6376539B1Substituted bicyclic lactonesBAYER AG·Filed 1999·Granted Apr 23, 2002·2 cites·11 claims
- 3135US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3235US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3335US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3434US6433004B1Substituted β,γ-anellated lactonesBAYER AG·Filed 1999·Granted Aug 13, 2002·1 cites·10 claims
- 3532US2017210738A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3632US2017226081A1Glucose transport inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Müller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →